Alimera Sciences Inc (ALIM)
3.63
+0.04
(+1.11%)
USD |
NASDAQ |
Apr 24, 16:00
3.45
-0.18
(-4.96%)
Pre-Market: 09:00
Alimera Sciences Cash from Investing (TTM): -75.53M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -75.53M |
September 30, 2023 | -75.53M |
June 30, 2023 | -75.66M |
March 31, 2023 | -0.115M |
December 31, 2022 | -0.255M |
September 30, 2022 | -0.292M |
June 30, 2022 | -0.472M |
March 31, 2022 | -0.686M |
December 31, 2021 | -0.621M |
September 30, 2021 | -0.585M |
June 30, 2021 | -0.593M |
March 31, 2021 | -0.679M |
December 31, 2020 | -0.62M |
September 30, 2020 | -0.559M |
June 30, 2020 | -0.352M |
March 31, 2020 | -0.184M |
December 31, 2019 | -0.174M |
September 30, 2019 | -0.151M |
June 30, 2019 | -0.091M |
March 31, 2019 | -0.099M |
December 31, 2018 | -0.175M |
September 30, 2018 | -0.178M |
June 30, 2018 | -0.194M |
March 31, 2018 | -0.272M |
December 31, 2017 | -0.238M |
Date | Value |
---|---|
September 30, 2017 | -0.298M |
June 30, 2017 | -0.237M |
March 31, 2017 | -0.168M |
December 31, 2016 | -0.186M |
September 30, 2016 | -0.203M |
June 30, 2016 | -0.23M |
March 31, 2016 | -0.366M |
December 31, 2015 | -0.451M |
September 30, 2015 | -26.05M |
June 30, 2015 | -25.97M |
March 31, 2015 | -25.99M |
December 31, 2014 | -25.84M |
September 30, 2014 | -0.75M |
June 30, 2014 | -0.802M |
March 31, 2014 | -0.957M |
December 31, 2013 | -0.973M |
September 30, 2013 | -0.394M |
June 30, 2013 | -0.393M |
March 31, 2013 | -0.051M |
December 31, 2012 | 0.477M |
September 30, 2012 | 0.481M |
June 30, 2012 | 0.461M |
March 31, 2012 | 0.397M |
December 31, 2011 | 25.72M |
September 30, 2011 | 39.35M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-75.66M
Minimum
Jun 2023
-0.091M
Maximum
Jun 2019
-12.27M
Average
-0.559M
Median
Sep 2020
Cash from Investing (TTM) Benchmarks
Eli Lilly and Co | -7.153B |
NovaBay Pharmaceuticals Inc | -0.019M |
Palatin Technologies Inc | 9.293M |
iBio Inc | 8.285M |
Theriva Biologics Inc | -0.202M |